Evidence map›Paper›PMID 39681738›Full record

ArticleJournal of robotic surgery2024

Tampa difficulty score: a scoring system for difficulty of robotic pancreaticoduodenectomy.

Sharona B Ross, Michelle M Dugan, Iswanto Sucandy, Maria Christodoulou, Tara Menon Pattilachan, Sneha Saravanan, Shlomi Rayman, Harel Jacoby, Alexander Rosemurgy

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharona B RossForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA. mysharonaross@gmail.com.
Michelle M DuganForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Iswanto SucandyForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Maria ChristodoulouForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Tara Menon PattilachanForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Sneha SaravananForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Shlomi RaymanDepartment of General Surgery, Assuta Ashdod Public Hospital, Ashdod, Israel.
Harel JacobyForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.
Alexander RosemurgyForegut and HPB Division, Digestive Health Institute AdventHealth Tampa, 3000 Medical Park Drive, Suite #500, Tampa, FL, 33613, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic platforms are increasingly utilized in surgery, offering unique technical advantages, though there is a scarcity of difficulty scoring systems (DSS) for these procedures. DSS aids in understanding operative complexities and enhancing preoperative planning. With IRB approval, data were collected on 200 consecutive adult patients who underwent robotic pancreaticoduodenectomy at a high-volume institution from 2019 to 2022. Linear regression was employed on clinical variables to analyze operative time and estimated blood loss as markers of surgical complexity. Weighted scoring system was developed using significant linear coefficient values, and an ANOVA analysis created the difficulty-level grouping system. Significant variables affecting operative time and/or EBL included: history of alcoholism, preoperative endoscopic intervention, tumor size, nodal disease on preoperative imaging, pancreatic duct dilation. These factors created the DSS ranging from 0 to 33. Group 1 (0-8, n = 9), Group 2 (9-20, n = 145), Group 3 (21-26, n = 37), and Group 4 (27-33, n = 9) showed significant differences in age, history of alcoholism, preoperative jaundice, tumor size, nodal disease, and operative metrics. Our novel DSS for robotic pancreaticoduodenectomy effectively predicts intraoperative challenges and aids in preoperative planning. Future steps include validating the system internally and externally.

Indexed as

Operative TimePancreaticoduodenectomyRobotic Surgical ProceduresAdultAgedAged, 80 and overBlood Loss, SurgicalFemaleHumansMaleMiddle AgedPancreatic NeoplasmsRobotic difficulty score systemRobotic pancreaticoduodenectomyRobotic pancreaticoduodenectomy difficulty levelTampa Difficulty Score

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.